Who Owns PVCT?

PROVECTUS BIOPHARMS — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

$19.3M

Shares Outstanding

Institutional Holders

7

Total Inst. Value

$23K

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

2

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1HOME FEDERAL BANK OF TENNESSEENew$10K100,000
2Wealth Preservation Advisors, LLCNew$5K52,000
3Atlas Wealth LLC$3K26,620
4ACADEMY CAPITAL MANAGEMENT$2K20,000
5LBMC INVESTMENT ADVISORS, LLC$2K20,000
6Financial Symmetry Inc$1K10,191
7HUNTINGTON NATIONAL BANK$01

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
HOME FEDERAL BANK OF TENNESSEENew+100K$10K
Wealth Preservation Advisors, LLCNew+52K$5K

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold PVCT?

As of Q1 2025, 7 institutional investors report holding PVCT (PROVECTUS BIOPHARMS) in their 13F filings.

Which hedge fund owns the most PVCT?

The largest institutional holder of PVCT is HOME FEDERAL BANK OF TENNESSEE with $10K in shares.

Are institutions buying or selling PVCT?

This quarter, 2 institutions opened new positions in PVCT and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.